OverviewSuggest Edit

AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.
HQNorcross, US

Latest Updates

Employees (est.) (Sep 2019)38(+3%)

AKESOgen Office Locations

AKESOgen has an office in Norcross
Norcross, US (HQ)
3155 Northwoods Pl NW
Show all (1)

AKESOgen Financials and Metrics

Summary Metrics

Founding Date


AKESOgen total Funding

$1.5 m

AKESOgen latest funding size

$1.31 m

Time since last funding

6 years ago
AKESOgen's latest funding round in January 2014 was reported to be $1.3 m. In total, AKESOgen has raised $1.5 m
Show all financial metrics

AKESOgen Online and Social Media Presence

Embed Graph

AKESOgen News and Updates

Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples

PRESS RELEASE: Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other approaches for assessing genetic risk for developing Alzheimer's disease, has collaborated with integrated genomics and genetics leader...

AKESOgen Blogs

RenalytixAI and AKESOgen In Joint Venture Partnership for Expanded Testing Capacity and Pharma Services

NEW YORK, Feb. 13, 2019 — RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility and provider of clinical trial p…

AKESOgen, Inc. Selected as a 2018 Atlanta Metro Export Challenge Winner

AKESOgen, Inc. Selected as a 2018 Atlanta Metro Export Challenge Winner AKESOgen, Inc. Receives $5,000 Grant to Grow Internationally ATLANTA – November 6th, 2018 AKESOgen, Inc. is a recipient of a $5,000 grant in the annual Atlanta Metro Export Challenge (Atlanta MEC), a grant program designed to en…

AKESOgen, Genetic Direction partner on Nutrisystem’s launch of Groundbreaking DNA Body Blueprint™ Nationwide

All New DNA Body Blueprint Provides Integrated Personal Action Plan Focusing on Genetic-Based Eating Behaviors, Nutrition and Metabolism Simple, Effective and Secure At-Home DNA Test is Supported by Science and Comprehensively Developed to Help Weight Loss and Weight Management FORT WASHINGTON, Pa.-…

AKESOgen Frequently Asked Questions

  • When was AKESOgen founded?

    AKESOgen was founded in 2010.

  • How many employees does AKESOgen have?

    AKESOgen has 38 employees.

  • Who are AKESOgen competitors?

    Competitors of AKESOgen include Juno Therapeutics, Idera Pharmaceuticals and VirtualScopics.

  • Where is AKESOgen headquarters?

    AKESOgen headquarters is located at 3155 Northwoods Pl NW, Norcross.

  • Where are AKESOgen offices?

    AKESOgen has an office in Norcross.

  • How many offices does AKESOgen have?

    AKESOgen has 1 office.